Search Breadcrumb Home Search Enter search keys … Jan 2016 Adv Virus Res Modified Vaccinia Virus Ankara: History, Value in Basic Research, and Current Perspectives for Vaccine Development Autoren Volz A Sutter G Nov 2015 Lancet Respir Med First-in-human trial of a live-attenuated Mycobacterium tuberculosis vaccine Autoren Geldmacher C Hatherill M Sep 2015 MBio A Highly Effective Component Vaccine against Nontyphoidal Salmonella enterica Infections Autoren Ferreira RB et al. Jul 2015 Viruses Genetic Diversity Underlying the Envelope Glycoproteins of Hepatitis C Virus: Structural and Functional Consequences and the Implications for Vaccine Design Autoren Tarr AW et al. Dec 2015 Science An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels Autoren Haagmans BL et al. Apr 2015 PLoS One Priming with a simplified intradermal HIV-1 DNA vaccine regimen followed by boosting with recombinant HIV-1 MVA vaccine is safe and immunogenic: a phase IIa randomized clinical trial Autoren Munseri PJ et al. May 2015 J Virol Comparable Antigenicity and Immunogenicity of Oligomeric Forms of a Novel, Acute HIV-1 Subtype C gp145 Envelope for Use in Preclinical and Clinical Vaccine Research Autoren Wieczorek L et al. Bitte verwenden Sie das Bild nur in Zusammenhang mit dieser Nachricht. © Foto: David Fußhöller, Universität Bonn Mar 11 2022 New strategy to protect from severe COVID-19 SARS-CoV-2 viruses can hide from recognition by the immune system when infecting cells, thereby delaying the onset of the immune response. Scientists around Prof Gunther Hartmann from the University Jan 2022 Cell Mol Immunol MCMV-based vaccine vectors expressing full-length viral proteins provide long-term humoral immune protection upon a single-shot vaccination Autoren Kim Y et al. Jan 2022 Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz [Development approaches for vaccines against hepatitis C virus infections] Autoren Bankwitz D Krey T Pietschmann T Pagination Previous page ‹‹ Seite 17 Seite 18 Seite 19 Seite 20 Current page 21 Seite 22 Seite 23 Seite 24 Seite 25 Seite 17 Seite 18 Seite 19 Seite 20 Seite 21 Seite 22 Seite 23 Seite 24 Seite 25 Next page ››
Jan 2016 Adv Virus Res Modified Vaccinia Virus Ankara: History, Value in Basic Research, and Current Perspectives for Vaccine Development Autoren Volz A Sutter G
Nov 2015 Lancet Respir Med First-in-human trial of a live-attenuated Mycobacterium tuberculosis vaccine Autoren Geldmacher C Hatherill M
Sep 2015 MBio A Highly Effective Component Vaccine against Nontyphoidal Salmonella enterica Infections Autoren Ferreira RB et al.
Jul 2015 Viruses Genetic Diversity Underlying the Envelope Glycoproteins of Hepatitis C Virus: Structural and Functional Consequences and the Implications for Vaccine Design Autoren Tarr AW et al.
Dec 2015 Science An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels Autoren Haagmans BL et al.
Apr 2015 PLoS One Priming with a simplified intradermal HIV-1 DNA vaccine regimen followed by boosting with recombinant HIV-1 MVA vaccine is safe and immunogenic: a phase IIa randomized clinical trial Autoren Munseri PJ et al.
May 2015 J Virol Comparable Antigenicity and Immunogenicity of Oligomeric Forms of a Novel, Acute HIV-1 Subtype C gp145 Envelope for Use in Preclinical and Clinical Vaccine Research Autoren Wieczorek L et al.
Jan 2022 Cell Mol Immunol MCMV-based vaccine vectors expressing full-length viral proteins provide long-term humoral immune protection upon a single-shot vaccination Autoren Kim Y et al.
Jan 2022 Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz [Development approaches for vaccines against hepatitis C virus infections] Autoren Bankwitz D Krey T Pietschmann T
